Dublin, Aug. 31, 2021 (GLOBE NEWSWIRE) -- The "Hematology Analyzers and Reagents Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product and Service; Application; End User, and Geography" report has been added to ResearchAndMarkets.com's offering.
The global hematology analyzers and reagents market is expected to reach US$ 13,007.87 million by 2027 from US$ 7,252.54 million in 2019. The market is estimated to grow at a CAGR of 7.57% from 2019 to 2027.
Increasing incidence of hematologic diseases and technological advancements in hematology analyzers are anticipated to drive the growth of the global hematology analyzers and reagents market during the forecast period. However, steep prices of high-tier systems are hindering the market growth.
Hematology analyzers and reagents are healthcare products and consumables intended to identify and count the individual blood cells in a high-speed manner and highly effective. These instruments have substituted the conventional methods of measuring blood cells individually under a microscope, which were previously carried out by the lab technicians. These devices provide more precise and useful blood cell results and other related information from the blood sample.
The impact of blood diseases is not necessarily limited to any one part of human body. A few of the common blood diseases include anemia; hemophilia; von Willebrand disease (VWD); and blood cancers such as myeloma, leukemia, and lymphoma. Several blood diseases are hereditary, and the rising prevalence of these diseases boosts demands for blood transfusion as well as blood cell counting for monitoring normalcy, which is further escalating the demand for hematology analyzers and reagents.
Anemia is a common blood disorder, and according to the National Heart, Lung, and Blood Institute, it affects more than 3 million Americans every year. Moreover, according to the World Health Organization (WHO), the disorder affected ~1.62 billion people worldwide in 2018. Anemia is also prevalent in Indian population and affects the quality of life of a remarkable number of people. According to the National Family Health Survey (NFHS) conducted in India in 2018, anemia affected ~58.6% of children and 50.4% of pregnant women in the country in 2016. Further, according to the Centers of Disease Control and Prevention (CDC), hemophilia A affects ~1 in 5,000 male births in the US on an average each year. A CDC survey for 2017 reported that VWD, one of the most common bleeding disorders, affects up to 1% of the general population. During 2012-2016, more than 14,600 men, women, and children were seen at hemophilia treatment centers for treatment of VWD. The increasing incidence of blood-related diseases is augmenting the growth of the hematology analyzers and reagents market.
Product and Service Insights
Based on product and service, the global hematology analyzers and reagents market is segmented into hematology products and services, hemostasis products and services, and immunohematology products and services. In 2019, the hematology products and services segment held the largest share in the market. The same segment is also expected to dominate the market by 2027 as it has diverse testing volumes that helps deliver accurate results. Moreover, these instruments are generally used in medical laboratories to detect protein or enzymes, and count blood cells in order to help in the diagnosis of illness and genetic defects.
Application Insights
Based on application, the global hematology analyzers and reagents market is segmented into anemia, blood cancer, hemorrhagic conditions, infection related conditions, and immune system related conditions, and other applications. The anemia segment held the largest market share in 2019, and it is also expected to dominate the market by 2027 as it is a medical condition in which the patient lacks enough healthy red blood cells to carry adequate oxygen to the tissues of the body.
End User Insights
In terms of end user, the global hematology analyzers and reagents market is segmented into hospital laboratories, commercial service providers, government reference laboratories, and academic and research institutes. In 2019, the hospital laboratories segment held the largest market share. Also, the same segment is expected to dominate the market during the forecast period as the blood collection and analysis devices are being frequently used in hospitals and pathology laboratories. Moreover, devices such as tubes, needles, holders, blood analyzers, and other consumables are utilized in the hospital during conduction of complete blood check-ups. In the laboratories, the collected/sampled blood is used for the clinical tests.
Key Topics Covered:
1. Introduction
2. Hematology Analyzers and Reagents Market - Key Takeaways
3. Research Methodology
3.1 Coverage645
3.2 Secondary Research
3.3 Primary Research
4. Global Hematology Analyzers and Reagents- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe- PEST Analysis
4.2.3 Asia Pacific- PEST Analysis
4.2.4 Middle East and Africa - PEST Analysis
4.2.5 South and Central America - PEST Analysis
4.3 Expert Opinions
5. Global Hematology Analyzers and Reagents Market - Key Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Hematologic Diseases
5.1.2 Technological Advancements in Hematology Analyzers
5.2 Market Restraints
5.2.1 Steep Prices of High-Tier Systems
5.3 Market Opportunities
5.3.1 Progress in Healthcare Sectors and Rise in Prevalence of Blood-Related Diseases in Emerging Economies
5.4 Future Trends
5.4.1 Escalating Adoption of Smart Point-of-Care Devices
5.5 Impact Analysis of Drivers and Restraints
6. Hematology Analyzers and Reagents Market - Global Analysis
6.1 Global Hematology Analyzers and Reagents Market Revenue Forecast And Analysis
6.2 Global Hematology Analyzers and Reagents Market, By Geography - Forecast And Analysis
6.3 Market Positioning
7. Hematology Analyzers and Reagents Market Analysis- by Product and Service
7.1 Overview
7.2 Global Hematology Analyzers and Reagents Market, by Product and Service, 2019 and 2027 (%)
7.3 Hematology Products and Services
7.3.1 Overview
7.3.2 Global Hematology Products and Services Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.3 Instruments
7.3.3.1 Overview
7.3.3.2 Global Instruments Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.4 Reagents and Consumables
7.3.4.1 Overview
7.3.4.2 Global Reagents and Consumables Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.5 Services
7.3.5.1 Overview
7.3.5.2 Global Services Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Hemostasis Products and Instruments
7.4.1 Overview
7.4.2 Global Hemostasis Products and Instruments Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.3 Instruments
7.4.3.1 Overview
7.4.3.2 Global Instruments Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.4 Reagents and Consumables
7.4.4.1 Overview
7.4.4.2 Global Reagents and Consumables Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.5 Services
7.4.5.1 Overview
7.4.5.2 Global Services Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Immunohematology Products and Services
7.5.1 Overview
7.5.2 Global Immunohematology Products and Services Market Revenue and Forecasts to 2027 (US$ Mn)
7.5.3 Instruments
7.5.3.1 Overview
7.5.3.2 Global Instruments Market Revenue and Forecasts to 2027 (US$ Mn)
7.5.4 Reagents and Consumables
7.5.4.1 Overview
7.5.4.2 Global Reagents and Consumables Market Revenue and Forecasts to 2027 (US$ Mn)
7.5.5 Services
7.5.5.1 Overview
7.5.5.2 Global Services Market Revenue and Forecasts to 2027 (US$ Mn)
8. Hematology Analyzers and Reagents Market Analysis- by Application
8.1 Overview
8.2 Global Hematology Analyzers and Reagents Market, by Application, 2019 and 2027 (%)
8.3 Anemia
8.3.1 Overview
8.3.2 Global Anemia Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Blood Cancer
8.4.1 Overview
8.4.2 Global Blood Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Haemorrhagic Conditions
8.5.1 Overview
8.5.2 Global Haemorrhagic Conditions Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Infection Related Conditions
8.6.1 Overview
8.6.2 Global Infection Related Conditions Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Immune System Related Conditions
8.7.1 Overview
8.7.2 Global Immune System Related Conditions Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Other Applications
8.8.1 Overview
8.8.2 Global Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)
9. Hematology Analyzers and Reagents Market Analysis- by End User
9.1 Overview
9.2 Global Hematology Analyzers and Reagents Market, by End User, 2019 and 2027 (%)
9.3 Hospital Laboratories
9.3.1 Overview
9.3.2 Global Hospital Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Commercial Service Providers
9.4.1 Overview
9.4.2 Global Commercial Service Providers Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Government Reference Laboratories
9.5.1 Overview
9.5.2 Global Government Reference Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Academic and Research Institutes
9.6.1 Overview
9.6.2 Global Academic and Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
10. Hematology Analyzers and Reagents Market - Geographic Analysis
11. Impact of COVID-19 Pandemic on Global Hematology Analyzers and Reagents Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
11.5 South & Central America: Impact Assessment of COVID-19 Pandemic
12. Hematology Analyzers and Reagents Market- Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. COMPANY PROFILES
13.1 Clinical Diagnostic Solutions, Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Danaher
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 BIO-RAD LABORATORIES INC.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Abbott
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Diatron
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 ERBA Diagnostics Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 EKF Diagnostics
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 HORIBA Medical
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Biosystems S.A.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/ilx7k
